Disparities in prostate cancer care | VJOncology
Episode 210: Olaparib/Abiraterone in Selected/Unselected Patients | GU Oncology Now
Silke Gillessen Sommer - Ticino Scienza
Theragnostic Talks 13. Lack of evidence? Is consensus an option? – with Silke Gillessen - Sam Nordic
The Uromigos Episode 267: ESMO 2023 Preview | GU Oncology Now
November 10, 2019 - EPOV Silke Gillessen - The ASCO Post
Exclusive Discussion on M1 Prostate Cancer: Chris Sweeney and Celestia Higano: 2017 Advanced Prostate Cancer Consensus Conference
Breast and prostate cancer: maintaining skeletal integrity | VJOncology
Prestigious appointment for Silke Gillessen | USI - Biomedicine
Silke GILLESSEN | Head of Department | Ente Ospedaliero Cantonale, Bellinzona | Oncology | Research profile
The Importance of Bone-Protecting Agents When Treating mCRPC with Bone Metastatic Disease The PEACE III Trial – Silke Gillessen
Silke Gillessen – Medical and Scientific Director of the IOSI (Oncology Institute of Southern Switzerland) – Ente Ospedaliero Cantonale (EOC) | LinkedIn
Il Covid-19 spaventa i pazienti oncologici. 'Andate dal medico' | laRegione.ch
Lack of evidence? Is consensus an option? – with Silke Gillessen | Theragnostic Talks
silke gillessen (@Silke_Gillessen) / X
silke gillessen (@Silke_Gillessen) / X
EOC - Ente Ospedaliero Cantonale - Gruppo “IOvember”: Ricercatori dello IOSI e dello IOR insieme per sostenere la salute maschile, il 19 novembre, giornata mondiale per la salute dell'uomo. Nella foto il
Silke Gillessen
Silke Gillessen – Medical and Scientific Director of the IOSI (Oncology Institute of Southern Switzerland) – Ente Ospedaliero Cantonale (EOC) | LinkedIn
ESMO Vision stories of Specialised Education: Silke Gillessen, ESMO Guidelines Committee member - YouTube
silke gillessen (@Silke_Gillessen) / X
Meetings - The ASCO Post
Dr. Silke Gillessen Invites You to Submit to ASCO #GU24 - YouTube
Updates on non-metastatic castration-resistant prostate cancer - ecancer
